Schedule 13D ownership disclosure

Kymera Therapeutics Inc

Security class unavailable · CUSIP: 501575104

Event date: 2024-03-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,997,706
Percent of class
9.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-041578
Form type
SC 13D
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Apr 01, 2024
Reporting period
Mar 28, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub